+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Real World Evidence"

From
From
From
From
Global eClinical Solutions Growth Opportunities - Product Thumbnail Image

Global eClinical Solutions Growth Opportunities

  • Report
  • March 2022
  • 82 Pages
  • Global
From
From
From
From
Clinical Trials - Impact of COVID-19 and Long COVID - Product Thumbnail Image

Clinical Trials - Impact of COVID-19 and Long COVID

  • Report
  • May 2023
  • 60 Pages
  • Global
From
From
Clinical Trials Sector Scorecard - Thematic Research - Product Thumbnail Image

Clinical Trials Sector Scorecard - Thematic Research

  • Report
  • October 2021
  • 24 Pages
  • Global
From
Clinical Trials - Real World Evidence - Product Thumbnail Image

Clinical Trials - Real World Evidence

  • Report
  • October 2021
  • 34 Pages
  • Global
From
Loading Indicator

The Real World Evidence (RWE) market within the context of E-Healthcare is a rapidly growing sector. It is a form of evidence-based medicine that uses data from real-world sources such as patient records, claims data, and observational studies to inform healthcare decisions. RWE can be used to assess the safety and effectiveness of treatments, identify new indications for existing treatments, and inform healthcare policy. It can also be used to assess the cost-effectiveness of treatments and to identify potential areas of improvement in healthcare delivery. RWE is increasingly being used by healthcare providers, payers, and pharmaceutical companies to inform their decisions. It is also being used by researchers to gain insights into the effectiveness of treatments and to identify potential areas of improvement in healthcare delivery. Some companies in the RWE market include IBM Watson Health, Optum, Flatiron Health, and Evidation Health. Show Less Read more